CYTOR and cancer: Consequently, gene products up-regulated by the ceRNA activity of linc00152 may be involved in the promotions of cell proliferation, survival, and cell motility and in the suppression of apoptosis, which suggests linc00152 is a potential oncogenic ceRNA that promotes cancer progression.